WallStreetZenWallStreetZen

NASDAQ: PTIX
Protagenic Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

PTIX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$6.0M
Current Profit Margin
0%

PTIX Return on Equity

Current Company
-156.4%
Current Industry
16.8%
Current Market
28.2%
PTIX's Return on Equity (-156.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PTIX announces earnings.

PTIX Return on Assets

Current Company
-124.8%
Current Industry
3.2%
PTIX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PTIX Return on Capital Employed

Current Company
-278.1%
Current Industry
-43.6%
PTIX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PTIX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PTIX$0.00-$5.89M-$6.01MN/AN/A
TFFP$885.72k-$19.41M-$19.93M+328.43%N/A
CVKD$0.00-$4.84M-$4.85MN/AN/A
ADIL$0.00-$8.71M-$8.69MN/AN/A
VIRI$0.00-$5.07M-$5.07MN/AN/A
View Top Biotech Stocks

Protagenic Therapeutics Earnings & Revenue FAQ

What were PTIX's earnings last quarter?

On Invalid Date, Protagenic Therapeutics (NASDAQ: PTIX) reported Q1 2024 earnings per share (EPS) of -$0.39, up 129.41% year over year. Total Protagenic Therapeutics earnings for the quarter were -$1.72 million. In the same quarter last year, Protagenic Therapeutics's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.

What was PTIX's earnings growth in the past year?

As of Q2 2024, Protagenic Therapeutics's earnings has grown year over year. Protagenic Therapeutics's earnings in the past year totalled -$6.01 million.

What was PTIX's revenue last quarter?

On Invalid Date, Protagenic Therapeutics (NASDAQ: PTIX) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Protagenic Therapeutics's revenue was $0.00.

What was PTIX's revenue growth in the past year?

As of Q2 2024, Protagenic Therapeutics's revenue has grown null year over year. Protagenic Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.